1 Erlotinib Hydrochloride API Market Overview 1.1 Product Overview and Scope of Erlotinib Hydrochloride API 1.2 Erlotinib Hydrochloride API Segment by Type 1.2.1 Global Erlotinib Hydrochloride API Market Size Growth Rate Analysis by Type 2021 VS 2027 1.2.2 Purity ≥ 98 % 1.2.3 Purity ≥ 99 % 1.3 Erlotinib Hydrochloride API Segment by Application 1.3.1 Global Erlotinib Hydrochloride API Consumption Comparison by Application: 2016 VS 2021 VS 2027 1.3.2 Erlotinib Hydrochloride Tablets 1.3.3 Other 1.4 Global Market Growth Prospects 1.4.1 Global Erlotinib Hydrochloride API Revenue Estimates and Forecasts (2016-2027) 1.4.2 Global Erlotinib Hydrochloride API Production Capacity Estimates and Forecasts (2016-2027) 1.4.3 Global Erlotinib Hydrochloride API Production Estimates and Forecasts (2016-2027) 1.5 Global Erlotinib Hydrochloride API Market by Region 1.5.1 Global Erlotinib Hydrochloride API Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027 1.5.2 North America Erlotinib Hydrochloride API Estimates and Forecasts (2016-2027) 1.5.3 Europe Erlotinib Hydrochloride API Estimates and Forecasts (2016-2027) 1.5.5 China Erlotinib Hydrochloride API Estimates and Forecasts (2016-2027) 1.5.5 Japan Erlotinib Hydrochloride API Estimates and Forecasts (2016-2027) 2 Market Competition by Manufacturers 2.1 Global Erlotinib Hydrochloride API Production Capacity Market Share by Manufacturers (2016-2021) 2.2 Global Erlotinib Hydrochloride API Revenue Market Share by Manufacturers (2016-2021) 2.3 Erlotinib Hydrochloride API Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.4 Global Erlotinib Hydrochloride API Average Price by Manufacturers (2016-2021) 2.5 Manufacturers Erlotinib Hydrochloride API Production Sites, Area Served, Product Types 2.6 Erlotinib Hydrochloride API Market Competitive Situation and Trends 2.6.1 Erlotinib Hydrochloride API Market Concentration Rate 2.6.2 Global 5 and 10 Largest Erlotinib Hydrochloride API Players Market Share by Revenue 2.6.3 Mergers & Acquisitions, Expansion 3 Production and Capacity by Region 3.1 Global Production Capacity of Erlotinib Hydrochloride API Market Share by Region (2016-2021) 3.2 Global Erlotinib Hydrochloride API Revenue Market Share by Region (2016-2021) 3.3 Global Erlotinib Hydrochloride API Production, Revenue, Price and Gross Margin (2016-2021) 3.4 North America Erlotinib Hydrochloride API Production 3.4.1 North America Erlotinib Hydrochloride API Production Growth Rate (2016-2021) 3.4.2 North America Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Europe Erlotinib Hydrochloride API Production 3.5.1 Europe Erlotinib Hydrochloride API Production Growth Rate (2016-2021) 3.5.2 Europe Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 China Erlotinib Hydrochloride API Production 3.6.1 China Erlotinib Hydrochloride API Production Growth Rate (2016-2021) 3.6.2 China Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Japan Erlotinib Hydrochloride API Production 3.7.1 Japan Erlotinib Hydrochloride API Production Growth Rate (2016-2021) 3.7.2 Japan Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Erlotinib Hydrochloride API Consumption by Region 4.1 Global Erlotinib Hydrochloride API Consumption by Region 4.1.1 Global Erlotinib Hydrochloride API Consumption by Region 4.1.2 Global Erlotinib Hydrochloride API Consumption Market Share by Region 4.2 North America 4.2.1 North America Erlotinib Hydrochloride API Consumption by Country 4.2.2 U.S. 4.2.3 Canada 4.3 Europe 4.3.1 Europe Erlotinib Hydrochloride API Consumption by Country 4.3.2 Germany 4.3.3 France 4.3.4 U.K. 4.3.5 Italy 4.3.6 Russia 4.4 Asia Pacific 4.4.1 Asia Pacific Erlotinib Hydrochloride API Consumption by Region 4.4.2 China 4.4.3 Japan 4.4.4 South Korea 4.4.5 Taiwan 4.4.6 Southeast Asia 4.4.7 India 4.4.8 Australia 4.5 Latin America 4.5.1 Latin America Erlotinib Hydrochloride API Consumption by Country 4.5.2 Mexico 4.5.3 Brazil 5 Production, Revenue, Price Trend by Type 5.1 Global Erlotinib Hydrochloride API Production Market Share by Type (2016-2021) 5.2 Global Erlotinib Hydrochloride API Revenue Market Share by Type (2016-2021) 5.3 Global Erlotinib Hydrochloride API Price by Type (2016-2021) 6 Consumption Analysis by Application 6.1 Global Erlotinib Hydrochloride API Consumption Market Share by Application (2016-2021) 6.2 Global Erlotinib Hydrochloride API Consumption Growth Rate by Application (2016-2021) 7 Key Companies Profiled 7.1 Cipla 7.1.1 Cipla Erlotinib Hydrochloride API Corporation Information 7.1.2 Cipla Erlotinib Hydrochloride API Product Portfolio 7.1.3 Cipla Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.1.4 Cipla Main Business and Markets Served 7.1.5 Cipla Recent Developments/Updates 7.2 Beaukev Pharma International 7.2.1 Beaukev Pharma International Erlotinib Hydrochloride API Corporation Information 7.2.2 Beaukev Pharma International Erlotinib Hydrochloride API Product Portfolio 7.2.3 Beaukev Pharma International Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.2.4 Beaukev Pharma International Main Business and Markets Served 7.2.5 Beaukev Pharma International Recent Developments/Updates 7.3 Beijing Lunarsun Pharmaceutical 7.3.1 Beijing Lunarsun Pharmaceutical Erlotinib Hydrochloride API Corporation Information 7.3.2 Beijing Lunarsun Pharmaceutical Erlotinib Hydrochloride API Product Portfolio 7.3.3 Beijing Lunarsun Pharmaceutical Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.3.4 Beijing Lunarsun Pharmaceutical Main Business and Markets Served 7.3.5 Beijing Lunarsun Pharmaceutical Recent Developments/Updates 7.4 Brawn Laboratories 7.4.1 Brawn Laboratories Erlotinib Hydrochloride API Corporation Information 7.4.2 Brawn Laboratories Erlotinib Hydrochloride API Product Portfolio 7.4.3 Brawn Laboratories Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.4.4 Brawn Laboratories Main Business and Markets Served 7.4.5 Brawn Laboratories Recent Developments/Updates 7.5 Jeil Pharmaceutical 7.5.1 Jeil Pharmaceutical Erlotinib Hydrochloride API Corporation Information 7.5.2 Jeil Pharmaceutical Erlotinib Hydrochloride API Product Portfolio 7.5.3 Jeil Pharmaceutical Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.5.4 Jeil Pharmaceutical Main Business and Markets Served 7.5.5 Jeil Pharmaceutical Recent Developments/Updates 7.6 Fabbrica Italiana Sintetici 7.6.1 Fabbrica Italiana Sintetici Erlotinib Hydrochloride API Corporation Information 7.6.2 Fabbrica Italiana Sintetici Erlotinib Hydrochloride API Product Portfolio 7.6.3 Fabbrica Italiana Sintetici Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.6.4 Fabbrica Italiana Sintetici Main Business and Markets Served 7.6.5 Fabbrica Italiana Sintetici Recent Developments/Updates 7.7 J&H Chemical 7.7.1 J&H Chemical Erlotinib Hydrochloride API Corporation Information 7.7.2 J&H Chemical Erlotinib Hydrochloride API Product Portfolio 7.7.3 J&H Chemical Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.7.4 J&H Chemical Main Business and Markets Served 7.7.5 J&H Chemical Recent Developments/Updates 7.8 Qilu Pharmaceutial 7.8.1 Qilu Pharmaceutial Erlotinib Hydrochloride API Corporation Information 7.8.2 Qilu Pharmaceutial Erlotinib Hydrochloride API Product Portfolio 7.8.3 Qilu Pharmaceutial Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.8.4 Qilu Pharmaceutial Main Business and Markets Served 7.7.5 Qilu Pharmaceutial Recent Developments/Updates 7.9 Zhuhai Rundu Pharma 7.9.1 Zhuhai Rundu Pharma Erlotinib Hydrochloride API Corporation Information 7.9.2 Zhuhai Rundu Pharma Erlotinib Hydrochloride API Product Portfolio 7.9.3 Zhuhai Rundu Pharma Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.9.4 Zhuhai Rundu Pharma Main Business and Markets Served 7.9.5 Zhuhai Rundu Pharma Recent Developments/Updates 7.10 Fuan Pharmaceutical Group 7.10.1 Fuan Pharmaceutical Group Erlotinib Hydrochloride API Corporation Information 7.10.2 Fuan Pharmaceutical Group Erlotinib Hydrochloride API Product Portfolio 7.10.3 Fuan Pharmaceutical Group Erlotinib Hydrochloride API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.10.4 Fuan Pharmaceutical Group Main Business and Markets Served 7.10.5 Fuan Pharmaceutical Group Recent Developments/Updates 8 Erlotinib Hydrochloride API Manufacturing Cost Analysis 8.1 Erlotinib Hydrochloride API Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Key Raw Materials Price Trend 8.1.3 Key Suppliers of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Erlotinib Hydrochloride API 8.4 Erlotinib Hydrochloride API Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers 9.1 Marketing Channel 9.2 Erlotinib Hydrochloride API Distributors List 9.3 Erlotinib Hydrochloride API Customers 10 Market Dynamics 10.1 Erlotinib Hydrochloride API Industry Trends 10.2 Erlotinib Hydrochloride API Growth Drivers 10.3 Erlotinib Hydrochloride API Market Challenges 10.4 Erlotinib Hydrochloride API Market Restraints 11 Production and Supply Forecast 11.1 Global Forecasted Production of Erlotinib Hydrochloride API by Region (2022-2027) 11.2 North America Erlotinib Hydrochloride API Production, Revenue Forecast (2022-2027) 11.3 Europe Erlotinib Hydrochloride API Production, Revenue Forecast (2022-2027) 11.4 China Erlotinib Hydrochloride API Production, Revenue Forecast (2022-2027) 11.5 Japan Erlotinib Hydrochloride API Production, Revenue Forecast (2022-2027) 12 Consumption and Demand Forecast 12.1 Global Forecasted Demand Analysis of Erlotinib Hydrochloride API 12.2 North America Forecasted Consumption of Erlotinib Hydrochloride API by Country 12.3 Europe Market Forecasted Consumption of Erlotinib Hydrochloride API by Country 12.4 Asia Pacific Market Forecasted Consumption of Erlotinib Hydrochloride API by Region 12.5 Latin America Forecasted Consumption of Erlotinib Hydrochloride API by Country 13 Forecast by Type and by Application (2022-2027) 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027) 13.1.1 Global Forecasted Production of Erlotinib Hydrochloride API by Type (2022-2027) 13.1.2 Global Forecasted Revenue of Erlotinib Hydrochloride API by Type (2022-2027) 13.1.3 Global Forecasted Price of Erlotinib Hydrochloride API by Type (2022-2027) 13.2 Global Forecasted Consumption of Erlotinib Hydrochloride API by Application (2022-2027) 14 Research Finding and Conclusion 15 Methodology and Data Source 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Author List 15.4 Disclaimer

List of Tables Table 1. Global Erlotinib Hydrochloride API Market Size by Type (MT) & (US$ Million) (2021 VS 2027) Table 2. Global Erlotinib Hydrochloride API Consumption (MT) Comparison by Application: 2016 VS 2021 VS 2027 Table 3. Erlotinib Hydrochloride API Market Size Comparison by Region: 2016 VS 2021 VS 2027 Table 4. Global Erlotinib Hydrochloride API Production Capacity (MT) by Manufacturers Table 5. Global Erlotinib Hydrochloride API Production (MT) by Manufacturers (2016-2021) Table 6. Global Erlotinib Hydrochloride API Production Market Share by Manufacturers (2016-2021) Table 7. Global Erlotinib Hydrochloride API Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Erlotinib Hydrochloride API Revenue Share by Manufacturers (2016-2021) Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Erlotinib Hydrochloride API as of 2020) Table 10. Global Market Erlotinib Hydrochloride API Average Price (USD/Kg) of Key Manufacturers (2016-2021) Table 11. Manufacturers Erlotinib Hydrochloride API Production Sites and Area Served Table 12. Manufacturers Erlotinib Hydrochloride API Product Types Table 13. Mergers & Acquisitions, Expansion Table 14. Global Erlotinib Hydrochloride API Production Capacity (MT) by Region (2016-2021) Table 15. Global Erlotinib Hydrochloride API Production (MT) by Region (2016-2021) Table 16. Global Erlotinib Hydrochloride API Revenue (US$ Million) by Region (2016-2021) Table 17. Global Erlotinib Hydrochloride API Revenue Market Share by Region (2016-2021) Table 18. Global Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 19. North America Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 20. Europe Erlotinib Hydrochloride API Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 21. China Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 22. Japan Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 23. Global Erlotinib Hydrochloride API Consumption Market by Region (2016-2021) & (MT) Table 24. Global Erlotinib Hydrochloride API Consumption Market Share by Region (2016-2021) Table 25. North America Erlotinib Hydrochloride API Consumption by Country (2016-2021) & (MT) Table 26. Europe Erlotinib Hydrochloride API Consumption by Country (2016-2021) & (MT) Table 27. Asia Pacific Erlotinib Hydrochloride API Consumption by Region (2016-2021) & (MT) Table 28. Latin America Erlotinib Hydrochloride API Consumption by Countries (2016-2021) & (MT) Table 29. Global Erlotinib Hydrochloride API Production (MT) by Type (2016-2021) Table 30. Global Erlotinib Hydrochloride API Production Market Share by Type (2016-2021) Table 31. Global Erlotinib Hydrochloride API Revenue (US$ Million) by Type (2016-2021) Table 32. Global Erlotinib Hydrochloride API Revenue Share by Type (2016-2021) Table 33. Global Erlotinib Hydrochloride API Price (USD/Kg) by Type (2016-2021) Table 34. Global Erlotinib Hydrochloride API Consumption by Application (2016-2021) & (MT) Table 35. Global Erlotinib Hydrochloride API Consumption Market Share by Application (2016-2021) Table 36. Global Erlotinib Hydrochloride API Consumption Growth Rate by Application (2016-2021) Table 37. Cipla Erlotinib Hydrochloride API Corporation Information Table 38. Cipla Specification and Application Table 39. Cipla Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 40. Cipla Main Business and Markets Served Table 41. Cipla Recent Developments/Updates Table 42. Beaukev Pharma International Erlotinib Hydrochloride API Corporation Information Table 43. Beaukev Pharma International Specification and Application Table 44. Beaukev Pharma International Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 45. Beaukev Pharma International Main Business and Markets Served Table 46. Beaukev Pharma International Recent Developments/Updates Table 47. Beijing Lunarsun Pharmaceutical Erlotinib Hydrochloride API Corporation Information Table 48. Beijing Lunarsun Pharmaceutical Specification and Application Table 49. Beijing Lunarsun Pharmaceutical Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 50. Beijing Lunarsun Pharmaceutical Main Business and Markets Served Table 51. Beijing Lunarsun Pharmaceutical Recent Developments/Updates Table 52. Brawn Laboratories Erlotinib Hydrochloride API Corporation Information Table 53. Brawn Laboratories Specification and Application Table 54. Brawn Laboratories Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 55. Brawn Laboratories Main Business and Markets Served Table 56. Brawn Laboratories Recent Developments/Updates Table 57. Jeil Pharmaceutical Erlotinib Hydrochloride API Corporation Information Table 58. Jeil Pharmaceutical Specification and Application Table 59. Jeil Pharmaceutical Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 60. Jeil Pharmaceutical Main Business and Markets Served Table 61. Jeil Pharmaceutical Recent Developments/Updates Table 62. Fabbrica Italiana Sintetici Erlotinib Hydrochloride API Corporation Information Table 63. Fabbrica Italiana Sintetici Specification and Application Table 64. Fabbrica Italiana Sintetici Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 65. Fabbrica Italiana Sintetici Main Business and Markets Served Table 66. Fabbrica Italiana Sintetici Recent Developments/Updates Table 67. J&H Chemical Erlotinib Hydrochloride API Corporation Information Table 68. J&H Chemical Specification and Application Table 69. J&H Chemical Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 70. J&H Chemical Main Business and Markets Served Table 71. J&H Chemical Recent Developments/Updates Table 72. Qilu Pharmaceutial Erlotinib Hydrochloride API Corporation Information Table 73. Qilu Pharmaceutial Specification and Application Table 74. Qilu Pharmaceutial Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 75. Qilu Pharmaceutial Main Business and Markets Served Table 76. Qilu Pharmaceutial Recent Developments/Updates Table 77. Zhuhai Rundu Pharma Erlotinib Hydrochloride API Corporation Information Table 78. Zhuhai Rundu Pharma Specification and Application Table 79. Zhuhai Rundu Pharma Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 80. Zhuhai Rundu Pharma Main Business and Markets Served Table 81. Zhuhai Rundu Pharma Recent Developments/Updates Table 82. Fuan Pharmaceutical Group Erlotinib Hydrochloride API Corporation Information Table 83. Fuan Pharmaceutical Group Specification and Application Table 84. Fuan Pharmaceutical Group Erlotinib Hydrochloride API Production Capacity (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 85. Fuan Pharmaceutical Group Main Business and Markets Served Table 86. Fuan Pharmaceutical Group Recent Developments/Updates Table 87. Production Base and Market Concentration Rate of Raw Material Table 88. Key Suppliers of Raw Materials Table 89. Erlotinib Hydrochloride API Distributors List Table 90. Erlotinib Hydrochloride API Customers List Table 91. Erlotinib Hydrochloride API Market Trends Table 92. Erlotinib Hydrochloride API Growth Drivers Table 93. Erlotinib Hydrochloride API Market Challenges Table 94. Erlotinib Hydrochloride API Market Restraints Table 95. Global Erlotinib Hydrochloride API Production (MT) Forecast by Region (2022-2027) Table 96. North America Erlotinib Hydrochloride API Consumption Forecast by Country (2022-2027) & (MT) Table 97. Europe Erlotinib Hydrochloride API Consumption Forecast by Country (2022-2027) & (MT) Table 98. Asia Pacific Erlotinib Hydrochloride API Consumption Forecast by Region (2022-2027) & (MT) Table 99. Latin America Erlotinib Hydrochloride API Consumption Forecast by Country (2022-2027) & (MT) Table 100. Global Erlotinib Hydrochloride API Production Forecast by Type (2022-2027) & (MT) Table 101. Global Erlotinib Hydrochloride API Revenue Forecast by Type (2022-2027) & (US$ Million) Table 102. Global Erlotinib Hydrochloride API Price Forecast by Type (2022-2027) & (USD/Kg) Table 103. Global Erlotinib Hydrochloride API Consumption (MT) Forecast by Application (2022-2027) Table 104. Research Programs/Design for This Report Table 105. Key Data Information from Secondary Sources Table 106. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Erlotinib Hydrochloride API Figure 2. Global Erlotinib Hydrochloride API Market Share by Type: 2020 VS 2027 Figure 3. Purity ≥ 98 % Product Picture Figure 4. Purity ≥ 99 % Product Picture Figure 5. Global Erlotinib Hydrochloride API Market Share by Application: 2020 VS 2027 Figure 6. Erlotinib Hydrochloride Tablets Figure 7. Other Figure 8. Global Erlotinib Hydrochloride API Revenue (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Erlotinib Hydrochloride API Revenue (US$ Million) (2016-2027) Figure 10. Global Erlotinib Hydrochloride API Production Capacity (MT) & (2016-2027) Figure 11. Global Erlotinib Hydrochloride API Production (MT) & (2016-2027) Figure 12. North America Erlotinib Hydrochloride API Revenue (US$ Million) and Growth Rate (2016-2027) Figure 13. Europe Erlotinib Hydrochloride API Revenue (US$ Million) and Growth Rate (2016-2027) Figure 14. China Erlotinib Hydrochloride API Revenue (US$ Million) and Growth Rate (2016-2027) Figure 15. Japan Erlotinib Hydrochloride API Revenue (US$ Million) and Growth Rate (2016-2027) Figure 16. Erlotinib Hydrochloride API Production Share by Manufacturers in 2020 Figure 17. Global Erlotinib Hydrochloride API Revenue Share by Manufacturers in 2020 Figure 18. Erlotinib Hydrochloride API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 19. Global Market Erlotinib Hydrochloride API Average Price (USD/Kg) of Key Manufacturers in 2020 Figure 20. The Global 5 and 10 Largest Players: Market Share by Erlotinib Hydrochloride API Revenue in 2020 Figure 21. Global Erlotinib Hydrochloride API Production Market Share by Region (2016-2021) Figure 22. North America Erlotinib Hydrochloride API Production (MT) Growth Rate (2016-2021) Figure 23. Europe Erlotinib Hydrochloride API Production (MT) Growth Rate (2016-2021) Figure 24. China Erlotinib Hydrochloride API Production (MT) Growth Rate (2016-2021) Figure 25. Japan Erlotinib Hydrochloride API Production (MT) Growth Rate (2016-2021) Figure 26. Global Erlotinib Hydrochloride API Consumption Market Share by Region (2016-2021) Figure 27. Global Erlotinib Hydrochloride API Consumption Market Share by Region in 2020 Figure 28. North America Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 29. North America Erlotinib Hydrochloride API Consumption Market Share by Country in 2020 Figure 30. Canada Erlotinib Hydrochloride API Consumption Growth Rate (2016-2021) & (MT) Figure 31. U.S. Erlotinib Hydrochloride API Consumption Growth Rate (2016-2021) & (MT) Figure 32. Europe Erlotinib Hydrochloride API Consumption Growth Rate (2016-2021) & (MT) Figure 33. Europe Erlotinib Hydrochloride API Consumption Market Share by Country in 2020 Figure 34. Germany America Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 35. France Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 36. U.K. Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 37. Italy Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 38. Russia Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 39. Asia Pacific Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 40. Asia Pacific Erlotinib Hydrochloride API Consumption Market Share by Regions in 2020 Figure 41. China Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 42. Japan Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 43. South Korea Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 44. Taiwan Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 45. Southeast Asia Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 46. India Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 47. Australia Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 48. Latin America Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 49. Latin America Erlotinib Hydrochloride API Consumption Market Share by Country in 2020 Figure 50. Mexico Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 51. Brazil Erlotinib Hydrochloride API Consumption and Growth Rate (2016-2021) & (MT) Figure 52. Production Market Share of Erlotinib Hydrochloride API by Type (2016-2021) Figure 53. Production Market Share of Erlotinib Hydrochloride API by Type in 2020 Figure 54. Revenue Share of Erlotinib Hydrochloride API by Type (2016-2021) Figure 55. Revenue Market Share of Erlotinib Hydrochloride API by Type in 2020 Figure 56. Global Erlotinib Hydrochloride API Consumption Market Share by Application (2016-2021) Figure 57. Global Erlotinib Hydrochloride API Consumption Market Share by Application in 2020 Figure 58. Global Erlotinib Hydrochloride API Consumption Growth Rate by Application (2016-2021) Figure 59. Key Raw Materials Price Trend Figure 60. Manufacturing Cost Structure of Erlotinib Hydrochloride API Figure 61. Manufacturing Process Analysis of Erlotinib Hydrochloride API Figure 62. Erlotinib Hydrochloride API Industrial Chain Analysis Figure 63. Channels of Distribution Figure 64. Distributors Profiles Figure 65. Global Erlotinib Hydrochloride API Production Market Share Forecast by Region (2022-2027) Figure 66. North America Erlotinib Hydrochloride API Production (MT) Growth Rate Forecast (2022-2027) Figure 67. Europe Erlotinib Hydrochloride API Production (MT) Growth Rate Forecast (2022-2027) Figure 68. China Erlotinib Hydrochloride API Production (MT) Growth Rate Forecast (2022-2027) Figure 69. Japan Erlotinib Hydrochloride API Production (MT) Growth Rate Forecast (2022-2027) Figure 70. Global Forecasted Demand Analysis of Erlotinib Hydrochloride API (2015-2027) & (MT) Figure 71. Global Erlotinib Hydrochloride API Production Market Share Forecast by Type (2022-2027) Figure 72. Global Erlotinib Hydrochloride API Revenue Market Share Forecast by Type (2022-2027) Figure 73. Global Erlotinib Hydrochloride API Consumption Forecast by Application (2022-2027) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation

Cipla Beaukev Pharma International Beijing Lunarsun Pharmaceutical Brawn Laboratories Jeil Pharmaceutical Fabbrica Italiana Sintetici J&H Chemical Qilu Pharmaceutial Zhuhai Rundu Pharma Fuan Pharmaceutical Group